BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9194669)

  • 1. Targeted drug delivery in gynaecology: the first uterine pass effect.
    Bulletti C; de Ziegler D; Flamigni C; Giacomucci E; Polli V; Bolelli G; Franceschetti F
    Hum Reprod; 1997 May; 12(5):1073-9. PubMed ID: 9194669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine contractility: vaginal administration of the beta-adrenergic agonist, terbutaline. Evidence of direct vagina-to-uterus transport.
    Bulletti C; de Ziegler D; de Moustier B; Polli V; Bolelli G; Franceschetti F; Flamigni C
    Ann N Y Acad Sci; 2001 Sep; 943():163-71. PubMed ID: 11594537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct transport of progesterone from vagina to uterus.
    Cicinelli E; de Ziegler D; Bulletti C; Matteo MG; Schonauer LM; Galantino P
    Obstet Gynecol; 2000 Mar; 95(3):403-6. PubMed ID: 10711552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first uterine pass effect.
    De Ziegler D; Bulletti C; De Monstier B; Jääskeläinen AS
    Ann N Y Acad Sci; 1997 Sep; 828():291-9. PubMed ID: 9329850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of uterine specificity of vaginal progesterone.
    Cicinelli E; Schonauer LM; Galantino P; Matteo MG; Cassetta R; Pinto V
    Hum Reprod; 2000 Jun; 15 Suppl 1():159-65. PubMed ID: 10928427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioautography of the uterus and vagina after [3H]progesterone injection into guinea pigs at various periods of the estrous cycle.
    Warembourg M; Milgrom E
    Endocrinology; 1977 Jan; 100(1):175-81. PubMed ID: 556602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraction of estrogens by human perfused uterus. Effects of membrane permeability and binding by serum proteins on differential influx into endometrium and myometrium.
    Bulletti C; Jasonni VM; Ciotti PM; Tabanelli S; Naldi S; Flamigni C
    Am J Obstet Gynecol; 1988 Aug; 159(2):509-15. PubMed ID: 2457321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus.
    Cicinelli E; de Ziegler D
    Hum Reprod Update; 1999; 5(4):365-72. PubMed ID: 10465526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptors in human oestrogen target tissues.
    van Haaften M; Wiegerinck MA; Poortman J; Haspels AA; Thijssen JH
    Maturitas; 1982 Apr; 4(1):57-66. PubMed ID: 7099004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of estrogen and antiestrogen in uterine cell nuclei: in vivo autoradiographic studies.
    Ennis BW; Stumpf WE
    J Steroid Biochem; 1988 Oct; 31(4A):405-9. PubMed ID: 3172774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal drug delivery: the first uterine pass effect.
    Bulletti C; De Ziegler D; Giacomucci E; Polli V; Rossi S; Alfieri S; Flamigni C
    Ann N Y Acad Sci; 1997 Sep; 828():285-90. PubMed ID: 9329849
    [No Abstract]   [Full Text] [Related]  

  • 12. Progesterone in the uterus. VI. On the question of the in vitro progesterone metabolism in human endometrium and myometrium.
    Egert D; Jonat W; Maass H
    Steroids; 1976 May; 27(5):703-15. PubMed ID: 941187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine progesterone metabolism during early pseudopregnancy in the rat.
    Redmond AF; Pepe GJ
    Biol Reprod; 1986 Nov; 35(4):949-55. PubMed ID: 3814706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments.
    Tavaniotou A; Smitz J; Bourgain C; Devroey P
    Hum Reprod Update; 2000; 6(2):139-48. PubMed ID: 10782572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further data favoring the hypothesis of the uterine first-pass effect of vaginally administered micronized progesterone.
    Balasch J; Fábregues F; Ordi J; Creus M; Peñarrubia J; Casamitjana R; Manau D; Vanrell JA
    Gynecol Endocrinol; 1996 Dec; 10(6):421-6. PubMed ID: 9032570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of natural progesterone vaginal suppository.
    von Eye Corleta H; Capp E; Ferreira MB
    Gynecol Obstet Invest; 2004; 58(2):105-8. PubMed ID: 15192285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.
    Miles RA; Paulson RJ; Lobo RA; Press MF; Dahmoush L; Sauer MV
    Fertil Steril; 1994 Sep; 62(3):485-90. PubMed ID: 8062942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic localization of [3H]RU 486 and [3H]progesterone in the uterus, pituitary and hypothalamus of the rat.
    Shi WL; Zhu PD
    Hum Reprod; 1990 Feb; 5(2):123-7. PubMed ID: 2324254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravaginal oestrogen and progestin administration: advantages and disadvantages.
    Cicinelli E
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):391-405. PubMed ID: 17981510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women.
    Cicinelli E; Cignarelli M; Sabatelli S; Romano F; Schonauer LM; Padovano R; Einer-Jensen N
    Fertil Steril; 1998 Mar; 69(3):471-3. PubMed ID: 9531879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.